BioSpace News Archive

Crown Aesthetics, a Crown Laboratories, Inc. company, is excited to announce the launch of BIOJUVE ™ , a novel skin biome brand that uses a clinically-proven, living microbe technology to optimize the overall skin biome and lead to healthier, younger-looking skin.

KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment.

Iantrek today announced the publication of 12-month clinical results of a novel bio-stenting procedure using the company’s microsurgical instrumentation in the prestigious peer-reviewed journal British Journal of Ophthalmology.

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies (tumor infiltrating lymphocyte, TIL, and peripheral-blood lymphocyte, PBL), today provided corporate, clinical, and regulatory updates.

Biosense Webster, Inc. announced that data from five company-sponsored studies, including two late breakers, will be presented at the 28th Annual International AF Symposium in Boston from February 2–4.

Thermo Fisher Scientific, the world leader in serving science, today announced the launch of its CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit, a Sanger sequencing-based assay that examines positive samples of human immunodeficiency virus (HIV) to identify genetic variants that may resist common antiretroviral therapeutics.

Takeda announced that it has entered into an exclusive licensing agreement with HUTCHMED Limited and its subsidiary HUTCHMED Limited, for the further development and commercialization of fruquintinib outside of mainland China, Hong Kong and Macau.

BiondVax Pharmaceuticals Ltd. today announced additional results in a preclinical proof-of-concept study of its innovative inhaled NanoAb COVID-19 drug.

Asensus Surgical, Inc. today announced receipt of CE Mark for an expansion of machine vision capabilities on the previously cleared Intelligent Surgical Unit™ (ISU™).

Ra Medical Systems, Inc. (NYSE American: RMED) (Ra Medical), a medical device and technology company focused on cardiac electrophysiology, announces that four abstracts with clinical data supporting its VIVO technology have been accepted for presentation at the European Heart Rhythm Association Congress (EHRA 2023) being held April 16-18, 2023 in Barcelona.